Variant report
Variant | nsv947123 |
---|---|
Chromosome Location | chr1:103201874-103207664 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549705248 | chr1:103201908-103201909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539426367 | chr1:103201912-103201913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560856735 | chr1:103201951-103201952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561515920 | chr1:103201975-103201976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557385598 | chr1:103201978-103201979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528916689 | chr1:103201997-103201998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575755650 | chr1:103202052-103202053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113220903 | chr1:103202064-103202065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187838876 | chr1:103202066-103202067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192360795 | chr1:103202078-103202079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541358447 | chr1:103202094-103202095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368385060 | chr1:103202105-103202106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560035736 | chr1:103202111-103202112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577919586 | chr1:103202124-103202125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545405261 | chr1:103202134-103202135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146801017 | chr1:103202136-103202137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531009888 | chr1:103202180-103202181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549527246 | chr1:103202228-103202229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561859195 | chr1:103202241-103202242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183734921 | chr1:103202258-103202259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547332550 | chr1:103202325-103202326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372387326 | chr1:103202327-103202328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565965770 | chr1:103202406-103202407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139506244 | chr1:103202433-103202434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543804865 | chr1:103202462-103202463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9970837 | chr1:103202463-103202464 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs569349334 | chr1:103202479-103202480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187521811 | chr1:103202482-103202483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555090135 | chr1:103202517-103202518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574142941 | chr1:103202542-103202543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74866136 | chr1:103202603-103202604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553361323 | chr1:103202620-103202621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs193000943 | chr1:103202724-103202725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142875456 | chr1:103202758-103202759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552311281 | chr1:103202794-103202795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184702532 | chr1:103202799-103202800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371846385 | chr1:103202802-103202803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs151055803 | chr1:103202839-103202840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563651735 | chr1:103202854-103202855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575752313 | chr1:103202881-103202882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189694066 | chr1:103202883-103202884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75845474 | chr1:103202916-103202917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529031408 | chr1:103202925-103202926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140838386 | chr1:103202937-103202938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368889495 | chr1:103202938-103202939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181739597 | chr1:103202946-103202947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150149999 | chr1:103203026-103203027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569762508 | chr1:103203047-103203048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551291150 | chr1:103203056-103203057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559985300 | chr1:103203080-103203081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:103200400-103202000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:103202000-103202200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:103202200-103203000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr1:103203000-103203600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr1:103203600-103204400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr1:103204400-103204600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:103205400-103206200 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr1:103205600-103206000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr1:103206200-103207800 | Weak transcription | Muscle Satellite Cultured Cells | -- |